Bradley Canino Score: 19
Analyst at
Guggenheim,
Stifel Nicolaus
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-22.1%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
29%
7 W / 17 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
33%
7 W / 14 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
14%
3 W / 18 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 21 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
26%
5 W / 14 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
27%
6 W / 16 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
50%
1 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Nov 04, 2025 |
Pyxis Oncology Inc
PYXS
|
BUY |
$7.00
Est. +84%
|
$3.81 | $5.55 |
Pending
|
$1.74
-54.3%
|
| Nov 22, 2024 |
Kura Oncology Inc
KURA
|
BUY |
$11.00
Est. +2%
|
$10.80 | $12.49 |
Target Met
|
$9.54
-11.7%
|
| Oct 21, 2024 |
Arvinas Inc
ARVN
|
BUY |
$63.00
Est. +132%
|
$27.11 | $29.61 |
Miss
|
$7.49
-72.4%
|
| Oct 14, 2024 |
Kura Oncology Inc
KURA
|
BUY |
$19.00
Est. +2%
|
$18.58 | $19.73 |
Target Met
|
$9.54
-48.7%
|
| Sep 19, 2024 |
Blueprint Medicines Corp
BPMC
|
BUY |
$155.00
Est. +70%
|
$90.94 | $129.65 |
Miss
|
$129.46
+42.4%
|
| Sep 16, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$135.00
Est. +54%
|
$87.45 | $113.51 |
Miss
|
$123.35
+41.1%
|
| Sep 05, 2024 |
Janux Therapeutics Inc
JANX
|
BUY |
$70.00
Est. +60%
|
$43.71 | $71.71 |
Precision Hit (±3%)
|
$13.74
-68.6%
|
| Sep 05, 2024 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$20.00
Est. +111%
|
$9.48 | $14.66 |
Miss
|
$8.40
-11.4%
|
| Aug 15, 2024 |
Celcuity Inc
CELC
|
BUY |
$39.00
Est. +135%
|
$16.57 | $53.86 |
Target Met
|
$88.24
+432.5%
|
| Aug 07, 2024 |
Pyxis Oncology Inc
PYXS
|
BUY |
$10.00
Est. +219%
|
$3.13 | $5.39 |
Miss
|
$1.74
-44.4%
|
| Jul 10, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$115.00
Est. +56%
|
$73.63 | $113.51 |
Precision Hit (±3%)
|
$123.35
+67.5%
|
| Jun 18, 2024 |
Zentalis Pharmaceuticals Inc
ZNTL
|
BUY |
$10.00
Est. +86%
|
$5.39 | $5.44 |
Miss
|
$3.75
-30.4%
|
| Jun 17, 2024 |
Merus N.V
MRUS
|
BUY |
$99.00
Est. +75%
|
$56.55 | $62.98 |
Miss
|
$90.00
+59.2%
|
| May 30, 2024 |
Celcuity Inc
CELC
|
BUY |
$40.00
Est. +162%
|
$15.28 | $19.77 |
Miss
|
$88.24
+477.5%
|
| May 28, 2024 |
Merus N.V
MRUS
|
BUY |
$90.00
Est. +64%
|
$54.80 | $59.38 |
Miss
|
$90.00
+64.2%
|
| May 23, 2024 |
Kura Oncology Inc
KURA
|
BUY |
$28.00
Est. +31%
|
$21.43 | $23.48 |
Miss
|
$9.54
-55.5%
|
| May 09, 2024 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$40.00
Est. +79%
|
$22.38 | $25.06 |
Miss
|
$18.48
-17.4%
|
| May 07, 2024 |
Zentalis Pharmaceuticals Inc
ZNTL
|
BUY |
$32.00
Est. +157%
|
$12.43 | $5.44 |
Miss
|
$3.75
-69.8%
|
| Apr 11, 2024 |
Arvinas Inc
ARVN
|
BUY |
$72.00
Est. +86%
|
$38.73 | $34.09 |
Miss
|
$7.49
-80.7%
|
| Apr 10, 2024 |
Alx Oncology Holdings Inc
ALXO
|
BUY |
$14.00
Est. +18%
|
$11.85 | $8.78 |
Miss
|
$1.58
-86.7%
|
| Apr 01, 2024 |
Affimed N.V.
AFMD
|
SELL |
$5.00
Est. +6%
|
$5.30 | $0.70 (Low) |
Target Met
|
$0.18
+96.6%
|
| Jul 29, 2022 |
Zentalis Pharmaceuticals Inc
ZNTL
|
BUY |
$70.00
Est. +146%
|
$28.50 | - | - |
$3.75
-86.8%
|
| Jun 13, 2022 |
Alx Oncology Holdings Inc
ALXO
|
BUY |
$16.00
Est. +136%
|
$6.79 | - | - |
$1.58
-76.7%
|
| Jun 03, 2022 |
Turning Point Therapeutics Inc
TPTX
|
SELL |
$73.60
Est. +0%
|
$73.71 | $75.30 (Low) |
Precision Hit (±3%)
|
$75.49
-2.4%
|
Pyxis Oncology Inc
PYXS
Nov 04, 2025
Signal & Target
BUY
$7.00
Start Price
$3.81
Best Price (1Y)
$5.55
Current Price
$1.74
Return
-54.3%
Kura Oncology Inc
KURA
Nov 22, 2024
Signal & Target
BUY
$11.00
Start Price
$10.80
Best Price (1Y)
$12.49
Current Price
$9.54
Return
-11.7%
Arvinas Inc
ARVN
Oct 21, 2024
Signal & Target
BUY
$63.00
Start Price
$27.11
Best Price (1Y)
$29.61
Current Price
$7.49
Return
-72.4%
Kura Oncology Inc
KURA
Oct 14, 2024
Signal & Target
BUY
$19.00
Start Price
$18.58
Best Price (1Y)
$19.73
Current Price
$9.54
Return
-48.7%
Blueprint Medicines Corp
BPMC
Sep 19, 2024
Signal & Target
BUY
$155.00
Start Price
$90.94
Best Price (1Y)
$129.65
Current Price
$129.46
Return
+42.4%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Sep 16, 2024
Signal & Target
BUY
$135.00
Start Price
$87.45
Best Price (1Y)
$113.51
Current Price
$123.35
Return
+41.1%
Janux Therapeutics Inc
JANX
Sep 05, 2024
Signal & Target
BUY
$70.00
Start Price
$43.71
Best Price (1Y)
$71.71
Current Price
$13.74
Return
-68.6%
ORIC Pharmaceuticals Inc
ORIC
Sep 05, 2024
Signal & Target
BUY
$20.00
Start Price
$9.48
Best Price (1Y)
$14.66
Current Price
$8.40
Return
-11.4%
Celcuity Inc
CELC
Aug 15, 2024
Signal & Target
BUY
$39.00
Start Price
$16.57
Best Price (1Y)
$53.86
Current Price
$88.24
Return
+432.5%
Pyxis Oncology Inc
PYXS
Aug 07, 2024
Signal & Target
BUY
$10.00
Start Price
$3.13
Best Price (1Y)
$5.39
Current Price
$1.74
Return
-44.4%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Jul 10, 2024
Signal & Target
BUY
$115.00
Start Price
$73.63
Best Price (1Y)
$113.51
Current Price
$123.35
Return
+67.5%
Zentalis Pharmaceuticals Inc
ZNTL
Jun 18, 2024
Signal & Target
BUY
$10.00
Start Price
$5.39
Best Price (1Y)
$5.44
Current Price
$3.75
Return
-30.4%
Merus N.V
MRUS
Jun 17, 2024
Signal & Target
BUY
$99.00
Start Price
$56.55
Best Price (1Y)
$62.98
Current Price
$90.00
Return
+59.2%
Celcuity Inc
CELC
May 30, 2024
Signal & Target
BUY
$40.00
Start Price
$15.28
Best Price (1Y)
$19.77
Current Price
$88.24
Return
+477.5%
Merus N.V
MRUS
May 28, 2024
Signal & Target
BUY
$90.00
Start Price
$54.80
Best Price (1Y)
$59.38
Current Price
$90.00
Return
+64.2%
Kura Oncology Inc
KURA
May 23, 2024
Signal & Target
BUY
$28.00
Start Price
$21.43
Best Price (1Y)
$23.48
Current Price
$9.54
Return
-55.5%
Syndax Pharmaceuticals Inc
SNDX
May 09, 2024
Signal & Target
BUY
$40.00
Start Price
$22.38
Best Price (1Y)
$25.06
Current Price
$18.48
Return
-17.4%
Zentalis Pharmaceuticals Inc
ZNTL
May 07, 2024
Signal & Target
BUY
$32.00
Start Price
$12.43
Best Price (1Y)
$5.44
Current Price
$3.75
Return
-69.8%
Arvinas Inc
ARVN
Apr 11, 2024
Signal & Target
BUY
$72.00
Start Price
$38.73
Best Price (1Y)
$34.09
Current Price
$7.49
Return
-80.7%
Alx Oncology Holdings Inc
ALXO
Apr 10, 2024
Signal & Target
BUY
$14.00
Start Price
$11.85
Best Price (1Y)
$8.78
Current Price
$1.58
Return
-86.7%
Affimed N.V.
AFMD
Apr 01, 2024
Signal & Target
SELL
$5.00
Start Price
$5.30
Best Price (1Y)
$0.70
Current Price
$0.18
Return
+96.6%
Zentalis Pharmaceuticals Inc
ZNTL
Jul 29, 2022
Signal & Target
BUY
$70.00
Start Price
$28.50
Best Price (1Y)
-
Current Price
$3.75
Return
-86.8%
Alx Oncology Holdings Inc
ALXO
Jun 13, 2022
Signal & Target
BUY
$16.00
Start Price
$6.79
Best Price (1Y)
-
Current Price
$1.58
Return
-76.7%
Turning Point Therapeutics Inc
TPTX
Jun 03, 2022
Signal & Target
SELL
$73.60
Start Price
$73.71
Best Price (1Y)
$75.30
Current Price
$75.49
Return
-2.4%